Chromium genotoxicity: A double-edged sword

Area of Science:

• Environmental Health
• Toxicology
• Molecular Biology

Background:

• Hexavalent chromium [Cr(VI)] is a known respiratory carcinogen.
• Cr(VI) induces extensive DNA damage through various mechanisms.
• Cellular uptake and metabolic reduction of Cr(VI) are key to its genotoxicity.

Purpose of the Study:

• To review the mechanisms of Cr(VI) carcinogenicity.
• To explore Cr(VI)-induced DNA damage and its consequences.
• To examine the role of cellular responses in Cr(VI) carcinogenesis.

Main Methods:

• Literature review of studies on Cr(VI) carcinogenicity.
• Analysis of Cr(VI) metabolic pathways and DNA interaction.
• Examination of cellular signaling and DNA repair in response to Cr(VI).

Main Results:

• Cr(VI) is reduced intracellularly to species that bind DNA, causing adducts, strand breaks, and crosslinks.
• Cr(VI) exposure leads to genomic instability, altered cell cycle control, and inflammation.
• Cellular survival pathways and DNA repair mechanisms are implicated in Cr(VI) resistance and neoplastic progression.

Conclusions:

• Cr(VI) carcinogenicity involves complex interactions between DNA damage, cellular responses, and signaling pathways.
• Understanding these mechanisms is crucial for assessing Cr(VI) risks and developing interventions.
• Cr(VI)-induced genotoxicity and subsequent cellular adaptations contribute to cancer development.